Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England.

and now certain breast cancer patients can benefit from the drug on the NHS. “It’s fantastic news that olaparib has been approved for use on the NHS in England, providing a second targeted ...

Patients in England with a form of breast cancer will be offered a new treatment after it was given the green light for NHS use. The Institute of Cancer Research, London, (ICR) – which worked on ...

Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to ...

A new site has been opened for breast cancer screening, available to women in the West Devon area ... “Patients will still be able to attend the mobile unit or University Hospitals Plymouth NHS Trust ...

Official figures show around 30 per cent of people invited for free NHS bowel cancer testing do not take up the invitation. A further 35 per cent of women don't attend breast screening ...

Patients in England with a form of breast cancer will be offered a new treatment after it was given the green light for NHS use. The Institute of Cancer Research, London, (ICR) – which worked on the ...

Hundreds of thousands more people will be sent a home-testing kit that can help to detect signs of bowel cancer, as the NHS expands its lifesaving screening programme to those aged 50 in England.

Tests can be ordered online from the NHS and completed at home, by taking a sample of saliva and sending it off to a laboratory. Those born with altered BRCA1 and BRCA2 genes have a greater risk of ...

Alarming statistics show there has been a rise in secondary breast cancer and according to a study of NHS admissions in 2021, it's estimated there are around 57,000 women in the UK living with the ...

Following entry into a commercial agreement with Bayer, NHS England is the first healthcare ... for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi ...

Most women will have been told to check their own breasts for signs of lumps and bumps, but after a certain age you'll be invited for a free NHS breast cancer screening. You'll automatically get ...